PBMCs from T2DM and T2DM-PDT patients exhibited increased GCL activity, observed exclusively in T2DM-PDT patients, and elevated GCL-catalytic subunit protein levels [43]. This evidence concerns the gene GCLC and type 2 diabetes mellitus.